Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
Recruiting · NCT03326947 · Registry updated 2024-02-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | Head and Neck Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 2 | 2024-02-20 | NCT03326947 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Jiao Tong University School of Medicine | 117 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University | Shanghai | China | 1 |